CARL
CARLSMED, INC.
Key Financials
Operating Income
$-30574000
↓ 26.7%
Net Income
$-29634000
↓ 22.2%
Total Liabilities
$31.3M
↑ 19.2%
Total Assets
$130.1M
↑ 151.1%
Shareholders' Equity
$98.9M
↑ 240.0%
Gross Profit
$38.0M
↑ 89.7%
Cash & Equivalents
$85.8M
↑ 113.8%
EPS (Diluted)
$-2.12
↑ 65.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/1/2026 | View on SEC |
| S-8 | 10/1/2026 | View on SEC |
| 3 | 9/30/2026 | View on SEC |
| 4 | 9/30/2026 | View on SEC |
| 3 | 9/30/2026 | View on SEC |
| 144 | 9/30/2026 | View on SEC |
| 8-K | 9/30/2026 | View on SEC |
| 4/A | 9/15/2026 | View on SEC |
| 4 | 9/10/2026 | View on SEC |
| 3 | 9/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CARL |
| Company Name | CARLSMED, INC. |
| CIK | 1794546 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 858-295-9290 |